Vitagliano S, Berrino L, Pizzirusso A, D'Amico M, Calderaro V, Maione S, Rossi F
Institute of Pharmacology and Toxicology, Faculty of Medicine and Surgery, II University of Naples, Italy.
Neuropharmacology. 1994 Jul;33(7):859-64. doi: 10.1016/0028-3908(94)90182-1.
The goal of the present study was to identify sites in the medulla oblongata where metabotropic glutamate receptors are involved in regulating respiration. Unilateral microinjections (50 nl) of L-glutamate (L-glu) (10-25-50 mM) into the nucleus tractus solitarii (NTS) of anaesthetized rats elicited apnea (8.6 +/- 0.3 sec; 21.3 +/- 3.6 sec; 66.3 +/- 16.5 sec respectively; N = 6) and arterial hypotension (7.3 +/- 2.4 mmHg; 10.1 +/- 2.3 mmHg; 35.3 +/- 7.5 mmHg respectively; N = 6). Similarly, in other rats 1-aminocyclopentane-1, 3-dicarboxylic acid (ACPD) (1-5-10 mM), a selective agonist of metabotrophic glutamate receptors, also induced apnea (22.4 +/- 2.5 sec; 32.5 +/- sec; 92.5 +/- 1.4 sec respectively; N = 6) and arterial hypotension (12.7 +/- 2.2 mmHg; 19.6 +/- 4.3 mmHg; 26.5 +/- 1.5 mmHg respectively; N = 6). Paired experiments showed that unilateral microinjections of L-glu (50 mM) and ACPD (1 mM) into the nucleus retroambigualis (NRA) of anaesthetized rats elicited apnea (20.2 +/- 2.6 sec and 33.8 +/- 3.2 sec respectively; N = 6) and arterial hypotension (15.7 +/- 3.7 mmHg and 22.5 +/- 4.5 mmHg respectively; N = 6). The ACPD effects on apnea and hypotension in NTS and NRA were not prevented by a 3 min pretreatment with L-AP3 (30 mM), a putative antagonist of metabotropic glutamate receptors (19.5 +/- 1.4 sec; 12.3 +/- 3.2 mmHg and 30.6 +/- 2.9 sec; 23.4 +/- 3.8 mmHg respectively; N = 6). These data suggest that metabotropic glutamate receptors are involved in NTS and NRA regulation of cardiorespiratory functions.(ABSTRACT TRUNCATED AT 250 WORDS)
本研究的目的是确定延髓中代谢型谷氨酸受体参与调节呼吸的部位。向麻醉大鼠的孤束核(NTS)单侧微量注射(50 nl)L-谷氨酸(L- glu)(10 - 25 - 50 mM)会引发呼吸暂停(分别为8.6±0.3秒;21.3±3.6秒;66.3±16.5秒;N = 6)和动脉低血压(分别为7.3±2.4 mmHg;10.1±2.3 mmHg;35.3±7.5 mmHg;N = 6)。同样,在其他大鼠中,代谢型谷氨酸受体的选择性激动剂1-氨基环戊烷-1,3-二羧酸(ACPD)(1 - 5 - 10 mM)也会引发呼吸暂停(分别为22.4±2.5秒;32.5±秒;92.5±1.4秒;N = 6)和动脉低血压(分别为12.7±2.2 mmHg;19.6±4.3 mmHg;26.5±1.5 mmHg;N = 6)。配对实验表明,向麻醉大鼠的疑后核(NRA)单侧微量注射L- glu(50 mM)和ACPD(1 mM)会引发呼吸暂停(分别为20.2±2.6秒和33.8±3.2秒;N = 6)和动脉低血压(分别为15.7±3.7 mmHg和22.5±4.5 mmHg;N = 6)。用代谢型谷氨酸受体的假定拮抗剂L-AP3(30 mM)预处理3分钟并不能阻止ACPD对NTS和NRA中呼吸暂停和低血压的影响(分别为19.5±1.4秒;12.3±3.2 mmHg和30.6±2.9秒;23.4±3.8 mmHg;N = 6)。这些数据表明,代谢型谷氨酸受体参与NTS和NRA对心肺功能的调节。(摘要截断于250字)